Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2022.12.05

Sai Life Sciences releases its Sustainability Report 2022

Sai Life Sciences releases its Sustainability Report 2022

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced the release of its Sustainability Report 2022, which has been developed as per the Global Reporting Initiative (GRI) standards. With the theme ‘Organising for Sustainability Success’ the Report describes the company’s efforts in progressively reducing the knowing-doing gap by proactively addressing sustainability-related material issues. Read the full report here.

Making the announcement, Krishna Kanumuri, CEO & Managing Director said, “Amid a backdrop of climate change and a recognition of urgency in implementing development goals, Sai Life Sciences continues to transform promises into action in its pursuit of sustainability. Our 2022 Sustainability Report, reflects sustained efforts across economic, environment and social cornerstones, and reiterates our ethos – Make it Better Together.”

The third report released by Sai Life Sciences reveals significant progress in multiple areas. Here are a few of the highlights:

  • Retained Silver Medal in the EcoVadis Business Sustainability assessment with an improvement in score from 57 to 63
  • Received LEED Gold certification for the Research & Technology (R&T) Centre in Hyderabad
  • Achieved increased utilization of renewable energy in manufacturing operations from 53% to 67%
  • Received Energy Management System - ISO 50001:2018 certification for Bidar Manufacturing unit
  • Awarded the CII Excellent Energy Efficient Unit for the third consecutive year at our Bidar API manufacturing unit
  • Qualified for the United Nations Global Compact (UNGC) Active Level based on the Communication on Progress (COP)

As part of its organizational transformative initiative, Sai Nxt, the company made significant progress in advancing its Sustainability agenda:

  • Became the first India-headquartered company to join the PSCI membership.
  • Joined ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) as an ‘Associate Member’.
  • Received ISO 14001:2015 and ISO 45001:2018 certifications.
  • Became a signatory of the United Nations Global Compact (UNGC).

The Sustainable Development Goals (SDGs) of the company had been set in 2019 with a three-year timeframe concluding in 2022. Incorporating the learnings from this period, the company is now in the process of envisioning goals and targets for the next phase of its journey.

Share article

More News

2025.09.05

Reviving Kudikunta Lake: Bringing nature and community closer together

As part of its Corporate Social Responsibility initiative, Sai Life Sciences has taken up the development of Kudikunta Lake in Hyderabad, reinforcing its commitment to sustainability and community well-being. The Kudikunta Lake initiative marks a significant step in restoring one of Hyderabad’s key lakes and advancing the cause of sustainable urban living. The company has […]
Read more

2025.09.05

From injections to pills: oral peptides set to transform drug development

In a recent article published in Drug Target Review, Dr Santosh Kulkarni highlights the shift from injections to pills. He writes about how oral peptide therapeutics are overcoming the long-standing challenge of poor bioavailability—bringing us closer to patient-friendly medicines without compromising efficacy. The article highlights the booming peptide drug market and the scientific advances—from chemical […]
Read more

2025.08.28

Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV). The Phase I of PB-11, with a capacity of 110 KL, was inaugurated […]
Read more

2025.08.20

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. […]
Read more

2025.08.20

Sai Life Sciences featured in Drug Discovery & Development on trends shaping drug discovery

Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP 1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these […]
Read more